Advertisement

Topics

Neuropathy Action Foundation Company Profile

10:46 EST 21st November 2017 | BioPortfolio


News Articles [908 Associated News Articles listed on BioPortfolio]

Diabetes, HbA1c, and Neuropathy

The hallmark of neuropathy associated with type 2 diabetes is reduction of sensory nerve action potential amplitude and not a reduction in conduction velocity, supporting the hypothesis that hyperglyc...

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 24, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ('Foundation' or the 'Company') (NASDAQ...

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 8, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Foundation Medicine, Inc. ('Foundation' or the 'Comp...

DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 25, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ("Foundation" or the "Company") (NAS...

UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 15, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ("Foundation" or the "Company") (NAS...

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 16, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ('Foundation' or the 'Company') (NASDAQ...

IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 22, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ("Foundation" or the "Company") (NASDAQ...

SHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Foundation Medicine, Inc. and Reminds Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 21, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Foundation Medicine, Inc. ("Foundation" or the "Company") (NAS...

Drugs and Medications [472 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [1035 Associated PubMed Articles listed on BioPortfolio]

An Evidence-Based Approach to the Differentiation of Compressive Neuropathy from Polysensory Neuropathy in the Upper Extremity.

Ethambutol optic neuropathy.

We provide a summary of the epidemiology, clinical findings, management and outcomes of ethambutol-induced optic neuropathy (EON). Ethambutol-induced optic neuropathy is a well-known, potentially irre...

The Comparison between Effects of 12 weeks Combined Training and Vitamin D Supplement on Improvement of Sensory-motor Neuropathy in type 2 Diabetic Women.

Peripheral neuropathy is a common complaint of diabetes. This study aimed to determine the effects of 12 weeks combined training with Vitamin D supplement on improvement of sensory-motor neuropathy in...

Increased Mortality and Comorbidity Associated With Leber's Hereditary Optic Neuropathy: A Nationwide Cohort Study.

Leber's hereditary optic neuropathy (LHON) is a mitochondrial genetic disease in which optic neuropathy is considered a key feature. Several other manifestations of LHON have been reported; however, o...

SFN-SIQ, SFNSL, and skin biopsy of 55 cases with small fiber involvement.

To date, there are no validated screening scales for small fiber neuropathy (SFN). This study investigated the Small-Fiber Neuropathy and Symptom Inventory Questionnaire (SFN-SIQ) as well as the Small...

Clinical Trials [1505 Associated Clinical Trials listed on BioPortfolio]

Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV

This preliminary study will investigate the use of Acupuncture and Moxibustion (Acu/Moxa) for distal symmetric peripheral neuropathy (DSP) associated with HIV applying traditional Chinese ...

Fall Risk Assessment in People With Diabetic Neuropathy

Fall risk is increased in people with diabetic peripheral neuropathy (DPN) and yet, minimal research has been conducted to identify appropriate fall risk assessment tools and improve our u...

A Study Comparing the Effectiveness and Safety of Tramadol HCl/Acetaminophen Versus Placebo for the Treatment of Painful Neuropathy in Diabetic Patients

The purpose of this study is to explore the pain-reieiving effects and safety of tramadol HCl/acetaminophen as compared to placebo in patients experiencing painful diabetic neuropathy. Tre...

Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy

The purpose of this study is to determine whether QR-333 is safe and effective in the treatment of diabetic neuropathy as compared to placebo.

Lidocaine for Oxaliplatin-induced Neuropathy

Oxaliplatin-induced neuropathy is a major dose-limiting side effect in patients with colorectal cancer treated with the FOLFOX chemotherapy regimen. Hypersensitivity to cold is the sensory...

Companies [1643 Associated Companies listed on BioPortfolio]

Neuropathy Action Foundation

Hereditary Neuropathy Foundation

Hereditary Neuropathy Foundation (HNF) is a non-profit 501(c)3 organization whose mission is to increase awareness and accurate diagnosis of Charcot-Marie-Tooth disease (CMT) and ...

The Arthur M. Blank Family Foundation

By convening individuals around issues, innovations and ideas that will shape the quality of life for families in Atlanta and beyond, the Blank Family Foundation aspires to spur civic action and citiz...

The Citizen CPR Foundation

Founded in 1987, the Citizen CPR Foundation (CCPRF) is a non-profit organization with the mission to save lives from sudden death by stimulating citizen and community action. Its ...

Action Pharma

Action Pharma is a privately owned Danish biotech company. The main strategy of Action Pharma is to develop novel drug candidates targeting melanocortin receptors and bring these to clinical proof...

More Information about "Neuropathy Action Foundation" on BioPortfolio

We have published hundreds of Neuropathy Action Foundation news stories on BioPortfolio along with dozens of Neuropathy Action Foundation Clinical Trials and PubMed Articles about Neuropathy Action Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuropathy Action Foundation Companies in our database. You can also find out about relevant Neuropathy Action Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record